Tagged with IT

AI Much has been written on the potential for artificial intelligence (AI) to change the way in which healthcare is conducted around the world, from expanding access to care in remote regions to increasing the efficiency with which patient data is stored and creating the ability to monitor a patient’s health…

Spain Carlos Mateos, founder and CEO of Spanish digital healthcare PR specialist, COM Salud, discusses opportunities for the healthcare sector in eHealth and big data as well as the benefits that holding eHealth congresses in Spain can bring to the entire healthcare sphere. What was the idea behind the creation of…

UK As the UK extracts itself from the European Union, key figures from the country’s life sciences sector are split on the implications of Brexit for their industry. “The UK pharmaceutical industry and the patients who rely on it are under serious threat from Brexit” Erik Nordkamp, Pfizer Erik Nordkamp, the…

India One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance. With a number of pharma manufacturers the recipients of warning letters from the US FDA, increased regulatory scrutiny has caused some consternation, but also progress in quality standards across the board. “I see…

Pharma While the automotive and electronics industries, among others, have been relatively fast in adopting robotics, pharma has been lagging behind. However, as the technology available becomes more advanced, flexible and affordable, robotics now stands as a pivotal element to helping pharmaceutical companies reduce costs and increase efficiency, notably in the…

UK Confirming Eisai’s commitment to keeping its EMEA headquarters in the UK, Gary Hendler, chairman and CEO EMEA, and Nick Burgin, COO and president of global value and access stress how the company is looking at Brexit as a glass half full. Eisai views Brexit as an opportunity to bring with…

Europe The top spenders on pharma R&D in Europe for 2015 were Switzerland – which spent over EUR 6.5 billion – followed by Germany – which spent EUR 6.2 billion – and the UK – which spent EUR 5.8 billion.

Spain Eva Prada, director of the British Chamber of Commerce in Spain, discusses trade relations between the UK and Spain and the activities of the Chamber in developing trust-based business relationships between companies and the government, their collaboration with key institutions such as ICEX, as well as their intention to work…

Spain Concha Almarza, general manager at IQVIA Spain, discusses the changes that the Spanish pharmaceutical market has witnessed over the last few years, highlighting the stringent cost-containment measures aimed at improving patient access to complex innovative drugs, the stabilization of generics penetration urging producers to expand their offering to other segments,…

Europe The most valuable pharma markets in Europe for 2015. Germany leads the way, followed by France, Italy and the UK. For more pharma facts and figures, click here.

UK Only 14 months in position, UK country president at Novartis, Haseeb Ahmad, shares insights into the company’s new strategy. He further analyses how Brexit can be a catalysing force for the UK to lead in life sciences and explains why the country has potential as a test bed for medicine…

Malta Dr. Josie Muscat, Chairman at Saint James Hospital Group, describes how he founded the only private healthcare group in Malta and led it to its huge success, as well as his insights on how to attract more talents and medical tourism to the island. Could you please introduce yourself to our…